ABSTRACT -Objective -This study aimed to evaluate the feasibility and clinicopathological characteristics of early gastric and esophageal cancers treated with endoscopic submucosal dissection (ESD) at five centers in Brazil. (range, 20-150 min). Complications included pneumomediastinum in two (12.5%) patients and stenosis in one (6.2%). Mean duration of follow-up was 8.6 months, with no local recurrence despite the presence of lateral margin compromise. Conclusion -Different centers in Brazil feasibly perform ESD with a high success rate.
INTRODUCTION
Since the first results of endoscopic submucosal dissection (ESD) (2, 5, 10) to treat early gastric cancer, its acceptance has been progressive in all the word. This technique allows en-bloc resection of lesions larger than 20 mm, providing a high accuracy of histological analysis and a reduced recurrence rate (2, 5) . The main limitations of ESD are its technical difficulty and higher rate of complications especially for beginners. Most studies on ESD come from Japanese experts.
In Brazil, ESD is not yet a common practice. Primarily due to technical difficulties of the method and low rates of gastric and esophageal cancer diagnosed at an early stage. For these reasons ESD has been restricted to tertiary referral centers. Recently, some reports of the European experience with ESD were
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published (11) . No similar study has been performed in Latin American countries. The aim of this study is to describe the results and outcomes of initial experience with ESD from five medical referral centers in Brazil.
METHODS
Five medical referral centers pioneering the use of ESD in Brazil participated in this study. Each center had their own group of endoscopists trained in centers of Japan or under the supervision of experienced Japanese endoscopists in Brazil. Group members were asked to complete an observation sheet for all consecutive patients treated by ESD.
All lesions were previously diagnosed by endoscopic biopsy. If available, ecoendoscopy was done. Patients were informed in detail about the ESD procedure and other treatment options. Clinicopathological features evaluated were: gender, age, tumor size, tumor location, macroscopic type, procedure time, en-block resection, complications, depth of invasion, lateral margins compromised and histologic type.
ESD was performed under sedation with midazolam, fentanyl, and propofol with constant monitoring of cardiorespiratory function during the procedure or under general anesthesia depending on the clinical condition of the patient. Using a standard video endoscope with 2% Lugol's solution for the esophagus and 0.4% indigo carmine for the stomach, the location, macroscopic type, and lateral extent of the lesion were determined. The procedure followed the steps recommended by Japanese authors as follow: a) marking outside the lesion; b) submucosal injection to produce a submucosal cushioning effect and lift the lesion; c) surrounding incision outside the marking; d) submucosal dissection. A transparent cap was attached to the tip of the endoscope if necessary (Figure 1 ).
Some different submucosal solutions were employed, including isotonic saline, hyaluronic acid, hydroxypropylmethyl cellulose (HPMC), and 10% mannitol. A small amount of indigo carmine was mixed in all solutions and injected with a 21-25 gauge injection needle. Circumferential incision and submucosal dissection were achieved with a variety of cutting devices, including: IT-knife, Flex-knife, Needle-knife (Olympus Corp., Tokyo, Japan), and flush-knife (Fujinon Corp., Omiya, Japan). The use of one or any combination of these accessories was the choice of the endoscopist. Complications such as bleeding or perforations were immediately treated with hemostatic forceps or hemoclips. Remaining visible vessels after completed ESD were also coagulated routinely to prevent delayed bleeding.
For gastric lesions the indication and cure criteria were adopted according to the expanded criteria described by Gotoda et al. (4) . For esophageal lesions, the indication and cure criteria were: endoscopic signs of early lesion or ecoendoscopic examination confirming tumor limited to the mucosa or up to the superficial submucosa (Sm1); histological confirmation of squamous cell carcinoma or high grade intraepithelial neoplasia restricted to the mucosa (M1 and M2); M3 lesions or those with Sm1 invasion without lymphatic and vascular involvement, superficial size less than 25 mm; no signs of lymph node metastases (1) .
RESULTS

Clinicopathological features
From in 76 patients were treated by ESD. Sixty-two lesions were located in the stomach and 16 in the esophagus. Mean age of patients with gastric lesions was 68 years (range, 32-83 years) and that for patients with esophageal lesions was 60.8 years (range, 48-83 years). Mean tumor size was 18.9 mm (range, 6-50 mm) for gastric lesions and 23.8 mm (range, 6-60 mm) for esophageal lesions.
Concerning location of gastric lesions, 31 (50.0%) were in the antrum, 22 (35.4%) in the body, 6 (9.6%) in the cardia, and 3 (0.5%) in the angular incisure. Of the 16 esophageal lesions, 10 (62.5%) were located at the distal portion, 5 (31.2%) at the mid portion, and 1 (6.2%) at the upper esophagus. Tables 1  and 2 reports clinicopathological data.
Endoscopic devices and injection solutions
The IT-knife was employed to remove 53 (85.5%) gastric and 9 (56.2%) esophageal lesions. The Flex-Knife was used for 4 (6.5%) gastric and 4 (25.0%) esophageal lesions; the Flush-Knife was employed for 5 (8.0%) gastric and 3 (18.8%) esophageal lesions. To lift the lesions, injection solutions included saline in 48 (61.5%) cases, mannitol in 16 (20.5%), HPMC in 10 (12.8%), and sodium hyaluronate in 4 (5.1%).
Histologic assessment and macroscopic tumor type
Of the 62 gastric lesions resected, 52 (83.8%) were well differentiated adenocarcinoma, 3 (4.8%) undifferentiated adenocarcinoma, 4 (6.4%) adenoma, 1 (1.6%) neuroendocrine neoplasia, 1 (1.6%) metaplasia and 1 (1.6%) hyperplasic lesion. 
Outcomes
En bloc resections were achieved for 51 (82.2%) of the 62 gastric lesions. Three (4.8%) of the en bloc resected tumors had lateral margin compromised. In two cases additional EMR was performed and the third case had submucosal invasion (Sm2) requiring surgical resection. As to the degree of invasion, 25 (40.3%) were M1, 13 (20.9%) M2, 20 (32.2%) M3, 3 (4.8%) Sm1, and 1 (1.6%) Sm2. All patients with Submcosal invasion underwent surgical treatment except for one patient, who was previously diagnosed with soft tissue sarcoma with multiple pulmonary metastases and referred to chemoteraphy. Median procedure time was 119.45 minutes (range, 20-300 min).
Of the 16 esophageal lesions, 13 (81.2%) were resected en bloc with 5 (31.2%) having lateral margin compromise. Because of technical difficulties, three lesions were resected piece meal, making it difficult to analyze lateral margins. Complications with esophageal resections were pneumomediastinum in two (12.5%) patients without evident perforation, diagnosed by x-ray, both treated with intravenous antibiotics and fasting. One (62%) patient developed stenosis and underwent endoscopic dilation.
Follow-up
Mean follow-up period for patients with gastric lesions was 11.3 months (range, 1-30 months) with two local recurrences and one death from pneumonia seven months after treatment. Two patients were found to have recurrent early gastric cancers during the follow-up period. One patient had two metachronous gastric lesions diagnosed 3 months after endoscopic resection; this patient was referred for surgical resection. The other patient was diagnosed one year after initial treatment, and underwent a second ESD. No recurrence was found at follow-up on year after the second ESD. Mean follow-up for the esophageal group was 8.6 months (range, 1-24 months) with no local recurrence despite the presence of lateral margin compromise.
DISCUSSION
The first live demonstration of ESD in Brazil aroused the interest of some endoscopic centers because of its expertise and advantageous results. The opportunity of exchanges with centers in Japan, were of the great importance to introducing ESD to Brazil (1) . ESD procedure duration and incidence of complication are directly related to the experience of the endoscopist.
Contrary to EMR, ESD allows large en-bloc resections contributing to better evaluation of resected specimens and consequently lower local recurrence rates. In this study, two cases were not confirmed malignant tumors after ESD. The procedure was important to discharge cancer in these cases.
The incidence of local recurrence after EMR procedures ranges from 2.3% to 36.5%, whereas initial studies of ESD report recurrence rates of 0% to 1% (4) . As for en-bloc resection of gastric cancer, success rates for both techniques are similar for lesions smaller than 1 cm in diameter, being greater than 90%. For lesions larger than 1 cm, ESD still shows a success rate over 90%, but EMR is successful in only half of the cases (14) . In the current study 82.2% of gastric lesions and 81.2% of esophageal lesions were removed en bloc. We considered a good rate for beginners. The expertise of the physicians involved in this study associated with proper training could explain this high rate of success.
The incidence of perforation with different EMR techniques ranges from 0% to 4.0%, whereas with ESD the rate is 0% to 5.0%. Comparing these methods, Watanabe et al. (14) did not verify a statistical difference in the incidence of perforation, 3.2% for EMR and 4.2% for ESD. However, Oka et al. (9) analyzed only nonulcerative lesions found an incidence of 0.5% for EMR and a 9.7% for EDS, which was statistically significant. In this study the rate of gastric perforation was 4,8%, all treated without surgery. Two cases after esophageal ESD had pneumomediastinum, without perforation. This is a relatively common complication that usually had a good outcome.
Bleeding is one of the most common complications in endoscopic resections. Oka and colleagus (9) verified that the incidence of bleeding during and after EMR was 7.6% and 3.9% for nonulcerative lesions; for ESD, rates were 22.6% and 6.2%, respectively. The bleeding is related with the lesion size and location. The absence of later bleeding in this study may be explained by the few cases of big lesions, since the average size of the gastric lesions was 1,8 cm. Lesions of the greater curvature also tends to bleed more, however we did not evaluate this data. The presence of lymph node metastasis is closely related to the degree of invasion into the esophageal and gastric wall. Esophageal lesions confined to the m1 and m2 layers do not present with lymph node metastasis. For deeper lesions Makuuchi H. (7) reported the following incidence of metastasis: m3 (9.1%), Sm1 (15.4%), Sm2 (40.0%), and Sm3 (44.1%). In this study, three cases were Sm1; these patients did not undergo surgery because of poor clinical condition.
In the stomach, the incidence of lymph node metastasis is considered irrelevant for lesions confined to the mucosa (m1 and m2) 0 to 3%. For lesions that invade the submucosa, the lymph node metastasis occurred from 9% to 19% (6) . In the past the Japanese Society of Gastric Cancer defined the following criteria for endoscopic resection (4, 8, 13) of gastric cancer based on results for endoscopic treatment and on the incidence of lymph node metastasis: non ulcerated or healed lesions, differentiated (IIa and IIb) type lesions smaller than 2 cm, and IIc type lesions smaller than 1 cm. If a patient was not a surgical candidate, submucosal resection may be considered for lesions larger than 2 cm and for those invading up to Sm1. For undifferentiated tumors, several authors did not advise endoscopic treatment because of the diffuse growth common to these lesions. Clinical observations using previously discussed criteria for endoscopic resections demonstrate that a significant number of patients undergo surgery unnecessarily. Gotoda et al. (3) analyzed data on more than 5,000 gastrectomies with D2 nodal dissections, defined the group at risk for lymph node metastasis, and expanded the criteria for endoscopic resection for gastric cancer by applying the ESD technique for: restricted to the mucosa differentiated nonulcerated lesions greater than 2 cm, ulcerated lesions less than or equal to 3 cm, and differentiated lesions with superficial submucosal invasion (Sm1) less than or equal to 3 cm (4, 12) . These expanded criteria increase the number of patients eligible for endoscopic treatment for gastric lesions and contributed to the acceptance of ESD.
In Brazil the ESD technique is becoming more widespread because of access to the necessary devices, particularly the IT-Knife and flush-knife, as well as training in live porcine models under supervision of Japanese experts. We believe that experimental training with experienced teachers is crucial for endoscopists beginning to use this technique. Some basic technical principles of each devise must be respected in order to achieve success.
Based on our results, we conclude that ESD has proven feasible in different Brazilian centers with a high success rate. However, we believe that this procedure should be reserved for experienced and trained endoscopists. Chaves 
